STTK
Biotechnology · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Shattuck Labs, Inc. publishes a filing, an earnings call transcript or a press release.
Get STTK alertsAndrew Neill is recorded as CFO at Shattuck Labs, Inc. (STTK). The newest filing on record that lists Andrew Neill as CFO at Shattuck Labs, Inc. (STTK) is dated April 8, 2026. The proxy statement of Shattuck Labs, Inc. reports total compensation of $883,433 for Andrew Neill in fiscal 2025, including a base salary of $467,160. Disclosed compensation is on record for 3 fiscal years. Andrew Neill has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Shattuck Labs, Inc. on September 8, 2026. Shattuck Labs, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Shattuck Labs, Inc. includes Taylor Schreiber (CEO and Board Member), George Golumbeski (Chairman), Stephen Stout (General Counsel) and 7 others.
“So following our phase one data set, as you know, we executed on a follow-on offering of 75 plus a 15% green shoe.”
“As Conor mentioned at the onset of the call, the full financial results for the third quarter 2023 are available in our 10-Q and earnings press release filed premarket this morning.”
“As Conor mentioned at the outset of the call, the full financial results for the fourth quarter and full-year ended December 31, 2022 are available in our earnings press release and in our Annual Report on Form 10-K. Today, I would like to focus on a few key points from our disclosures.”
“As Conor mentioned at the outset of our call, the full financial results for the third quarter of 2022 are available in our earnings press release and in our forthcoming 10-Q. Today, I would like to focus on a few key points from our disclosures.”
“As Conor mentioned, the full financial results for the second quarter of 2021 are available in our earnings press release and our forthcoming 10-Q. Today, I would like to focus on a few key points from our disclosures.”
Start not stated–present
Last confirmed April 8, 2026
STTK
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Shattuck Labs, Inc. (STTK) | Chief Financial Officer | $467,160 | $883,433 |
| 2024 | Shattuck Labs, Inc. (STTK) | Chief Financial Officer | $458,000 | $2,052,586 |
| 2023 | Shattuck Labs, Inc. (STTK) | Chief Financial Officer | $430,000 | $911,757 |